Page last updated: 2024-10-23

bisbenzimidazole and Esophageal Neoplasms

bisbenzimidazole has been researched along with Esophageal Neoplasms in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takashima, T1
Fujiwara, Y1
Hamaguchi, M1
Sasaki, E1
Tominaga, K1
Watanabe, T1
Oshitani, N1
Higuchi, K1
Arakawa, T1

Other Studies

1 other study available for bisbenzimidazole and Esophageal Neoplasms

ArticleYear
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Oncology reports, 2005, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; C

2005